Ion mobility mass spectrometry for the study of mycobacterial mycolic acids.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 11 03 2023
accepted: 25 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 27 6 2023
Statut: epublish

Résumé

Lipids are highly structurally diverse molecules involved in a wide variety of biological processes. The involvement of lipids is even more pronounced in mycobacteria, including the human pathogen Mycobacterium tuberculosis, which produces a highly complex and diverse set of lipids in the cell envelope. These lipids include mycolic acids, which are among the longest fatty acids in nature and can contain up to 90 carbon atoms. Mycolic acids are ubiquitously found in mycobacteria and are alpha branched and beta hydroxylated lipids. Discrete modifications, such as alpha, alpha', epoxy, methoxy, keto, and carboxy, characterize mycolic acids at the species level. Here, we used high precision ion mobility-mass spectrometry to build a database including 206 mass-resolved collision cross sections (CCSs) of mycolic acids originating from the strict human pathogen M. tuberculosis, the opportunistic strains M. abscessus, M. marinum and M. avium, and the nonpathogenic strain M. smegmatis. Primary differences between the mycolic acid profiles could be observed between mycobacterial species. Acyl tail length and modifications were the primary structural descriptors determining CCS magnitude. As a resource for researchers, this work provides a detailed catalogue of the mass-resolved collision cross sections for mycolic acids along with a workflow to generate and analyse the dataset generated.

Identifiants

pubmed: 37369807
doi: 10.1038/s41598-023-37641-9
pii: 10.1038/s41598-023-37641-9
pmc: PMC10300000
doi:

Substances chimiques

Mycolic Acids 0
Fatty Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10390

Subventions

Organisme : Medical Research Council
ID : MR/W018756/1
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Chem Biol. 2014 Jan 16;21(1):67-85
pubmed: 24374164
J Immunol. 2014 Jul 1;193(1):295-305
pubmed: 24907344
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W606-12
pubmed: 17584797
mBio. 2013 May 07;4(3):e00222-13
pubmed: 23653446
J Microbiol Methods. 2009 May;77(2):165-77
pubmed: 19318047
PLoS One. 2012;7(6):e39017
pubmed: 22720018
Annu Rev Biochem. 1995;64:29-63
pubmed: 7574484
J Lipid Res. 2011 May;52(5):861-72
pubmed: 21285232
Chem Biol. 2011 Dec 23;18(12):1537-49
pubmed: 22195556
Cold Spring Harb Perspect Med. 2014 Aug 07;4(10):
pubmed: 25104772
J Am Soc Mass Spectrom. 2022 Jan 5;33(1):149-159
pubmed: 34842433
Microbiology (Reading). 2001 Jul;147(Pt 7):1825-1837
pubmed: 11429460
Arch Microbiol. 1984 Oct;139(2-3):225-31
pubmed: 6517656
Mol Microbiol. 2015 Oct;98(1):7-16
pubmed: 26135034
Mass Spectrom Rev. 2022 Sep;41(5):722-765
pubmed: 33522625
Nat Commun. 2019 Feb 28;10(1):985
pubmed: 30816114
Parasitology. 2018 Feb;145(2):116-133
pubmed: 27976597
Curr Opin Chem Biol. 2018 Feb;42:42-50
pubmed: 29145156
Nat Methods. 2019 Apr;16(4):299-302
pubmed: 30886413
Microbiology (Reading). 2002 Jun;148(Pt 6):1881-1902
pubmed: 12055308
Nat Commun. 2020 Feb 4;11(1):684
pubmed: 32019932
EMBO Mol Med. 2012 Jan;4(1):27-37
pubmed: 22147526
J Am Soc Mass Spectrom. 2018 Nov;29(11):2182-2188
pubmed: 30047074
J Am Soc Mass Spectrom. 2019 Nov;30(11):2185-2195
pubmed: 31493234
Methods Mol Biol. 2021;2306:11-37
pubmed: 33954937
Biochem J. 2020 May 29;477(10):1983-2006
pubmed: 32470138
Prog Lipid Res. 2012 Oct;51(4):325-39
pubmed: 22659327
PLoS One. 2016 Oct 14;11(10):e0164253
pubmed: 27741286
Anal Chem. 2017 Sep 5;89(17):9048-9055
pubmed: 28763190
Chem Phys Lipids. 2010 Nov;163(8):800-8
pubmed: 20875402
Diagn Microbiol Infect Dis. 2013 Jul;76(3):298-305
pubmed: 23669043
Res Microbiol. 1991 May;142(4):397-403
pubmed: 1871424
Tuberculosis (Edinb). 2003;83(1-3):91-7
pubmed: 12758196
Prog Lipid Res. 1998 Jul-Aug;37(2-3):143-79
pubmed: 9829124
J Appl Microbiol. 2020 Jun;128(6):1547-1567
pubmed: 31595643
Anal Chem. 2001 Sep 15;73(18):4537-44
pubmed: 11575804
Chem Biol. 2009 May 29;16(5):499-509
pubmed: 19477414
PLoS Pathog. 2008 Nov;4(11):e1000204
pubmed: 19002241
J Mass Spectrom. 2008 Jan;43(1):1-22
pubmed: 18200615
Anal Chem. 2015 Jan 20;87(2):1137-44
pubmed: 25495617

Auteurs

Yi Liu (Y)

Centre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK.

Nadhira Kaffah (N)

Centre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK.

Sufyan Pandor (S)

Agilent Technologies, Inc., Cheadle, UK.

Mark J Sartain (MJ)

Agilent Technologies, Inc., Santa Clara, CA, 95051, USA.

Gerald Larrouy-Maumus (G)

Centre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK. g.larrouy-maumus@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH